The Effect of Cold Temperature on Increased Exacerbation of Chronic Obstructive Pulmonary Disease: A Nationwide Study

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Tseng, Ching Min ^a   Chen, Yung Tai ^a,b   Ou, Shuo Ming ^a   Hsiao, Yi Han ^a   Li, Szu Yuan ^a,c   Wang, Shuu Jiun ^a,c   Yang, Albert C ^a,c   Chen, Tzeng Ji ^a,c   Perng, Diahn Warng ^a,c  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b TAIPEI CITY HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AIR TEMPERATURE; ARTICLE; ATMOSPHERIC PRESSURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COLD EXPOSURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE EXACERBATION; ENVIRONMENTAL TEMPERATURE; FEMALE; GERIATRIC PATIENT; HUMAN; HUMIDITY; MAJOR CLINICAL STUDY; MALE; SEASONAL VARIATION; TEMPERATURE MEASUREMENT; TEMPERATURE SENSITIVITY;

AGED; AGED, 80 AND OVER; COLD TEMPERATURE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGISTRIES; RETROSPECTIVE STUDIES; TAIWAN;

EID: 84875015782     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057066     Document Type: Article

References (34)

1. Rodriguez-Roisin R, (2000) Toward a consensus definition for COPD exacerbations. Chest 117: 398S-401S.
2. Kanner RE, Anthonisen NR, Connett JE, (2001) Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. Am J Respir Crit Care Med 164: 358-364.
3. Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, et al. (1998) Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157: 1418-1422.
4. Soler-Cataluna JJ, Martinez-Garcia MA, Roman Sanchez P, Salcedo E, Navarro M, et al. (2005) Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 60: 925-931.
5. Jenkins CR, Celli B, Anderson JA, Ferguson GT, Jones PW, et al. (2012) Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study. Eur Respir J 39: 38-45.
6. Mannino DM, Buist AS, (2007) Global burden of COPD: risk factors, prevalence, and future trends. Lancet 370: 765-773.
7. Donaldson GC, Goldring JJ, Wedzicha JA, (2012) Influence of season on exacerbation characteristics in patients with COPD. Chest 141: 94-100.
8. Greenberg SB, Allen M, Wilson J, Atmar RL, (2000) Respiratory viral infections in adults with and without chronic obstructive pulmonary disease. Am J Respir Crit Care Med 162: 167-173.
9. Upshur RE, Moineddin R, Crighton EJ, Mamdani M, (2006) Interactions of viral pathogens on hospital admissions for pneumonia, croup and chronic obstructive pulmonary diseases: results of a multivariate time-series analysis. Epidemiol Infect 134: 1174-1178.
10. Wedzicha JA, Seemungal TA, (2007) COPD exacerbations: defining their cause and prevention. Lancet 370: 786-796.
11. Lin YK, Ho TJ, Wang YC, (2011) Mortality risk associated with temperature and prolonged temperature extremes in elderly populations in Taiwan. Environ Res 111: 1156-1163.
12. Liao CM, Chang SY, Chen SC, Chio CP, (2009) Influenza-associated morbidity in subtropical Taiwan. Int J Infect Dis 13: 589-599.
13. Maclure M, (1991) The case-crossover design: a method for studying transient effects on the risk of acute events. Am J Epidemiol 133: 144-153.
14. Basu R, Dominici F, Samet JM, (2005) Temperature and mortality among the elderly in the United States: a comparison of epidemiologic methods. Epidemiology 16: 58-66.
15. Navidi W, Weinhandl E, (2002) Risk set sampling for case-crossover designs. Epidemiology 13: 100-105.
16. Burge PS, Calverley PM, Jones PW, Spencer S, Anderson JA, et al. (2000) Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ 320: 1297-1303.
17. Ferrari U, Exner T, Wanka ER, Bergemann C, Meyer-Arnek J, et al. (2012) Influence of air pressure, humidity, solar radiation, temperature, and wind speed on ambulatory visits due to chronic obstructive pulmonary disease in Bavaria, Germany. Int J Biometeorol 56: 137-143.
18. Analitis A, Katsouyanni K, Biggeri A, Baccini M, Forsberg B, et al. (2008) Effects of cold weather on mortality: results from 15 European cities within the PHEWE project. Am J Epidemiol 168: 1397-1408.
19. Seemungal T, Harper-Owen R, Bhowmik A, Moric I, Sanderson G, et al. (2001) Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164: 1618-1623.
20. Koskela HO, Koskela AK, Tukiaineu HO, (1996) Bronchoconstriction due to cold weather in COPD. The roles of direct airway effects and cutaneous reflex mechanisms. Chest 110: 632-636.
21. Donaldson GC, Seemungal T, Jeffries DJ, Wedzicha JA, (1999) Effect of temperature on lung function and symptoms in chronic obstructive pulmonary disease. Eur Respir J 13: 844-849.
22. The Eurowinter Group (1997) Cold exposure and winter mortality from ischaemic heart disease, cerebrovascular disease, respiratory disease, and all causes in warm and cold regions of Europe. The Eurowinter Group. Lancet 349: 1341-1346.
23. Williams R, Rankin N, Smith T, Galler D, Seakins P, (1996) Relationship between the humidity and temperature of inspired gas and the function of the airway mucosa. Crit Care Med 24: 1920-1929.
24. Mann M, Patel K, Reardon JZ, Goldstein M, Godar TJ, et al. (1993) The influence of spring and summer New England meteorologic conditions on the respiratory status of patients with chronic lung disease. Chest 103: 1369-1374.
25. Rea H, McAuley S, Jayaram L, Garrett J, Hockey H, et al. (2010) The clinical utility of long-term humidification therapy in chronic airway disease. Respir Med 104: 525-533.
26. Rennard SI, Anderson W, ZuWallack R, Broughton J, Bailey W, et al. (2001) Use of a long-acting inhaled beta2-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 163: 1087-1092.
27. Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, et al. (2007) Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 356: 775-789.
28. Casaburi R, Mahler DA, Jones PW, Wanner A, San PG, et al. (2002) A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J 19: 217-224.
29. Lindemann J, Sannwald D, Wiesmiller K, (2008) Age-related changes in intranasal air conditioning in the elderly. Laryngoscope 118: 1472-1475.
30. Holmer I, (2000) Strategies for prevention of cold stress in the elderly. Int J Circumpolar Health 59: 267-272.
31. Hak E, van Essen GA, Buskens E, Stalman W, de Melker RA, (1998) Is immunising all patients with chronic lung disease in the community against influenza cost effective? Evidence from a general practice based clinical prospective cohort study in Utrecht, The Netherlands. J Epidemiol Community Health 52: 120-125.
32. Jackson LA, Neuzil KM, Yu O, Benson P, Barlow WE, et al. (2003) Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med 348: 1747-1755.
33. Tillett HE, Smith JW, Gooch CD, (1983) Excess deaths attributable to influenza in England and Wales: age at death and certified cause. Int J Epidemiol 12: 344-352.
34. Wongsurakiat P, Maranetra KN, Wasi C, Kositanont U, Dejsomritrutai W, et al. (2004) Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled study. Chest 125: 2011-2020.